Design, Synthesis and Biological Evaluation of Jahanyne Analogs As Cell Cycle Arrest Inducers

Baijun Ye,Jianmiao Gong,Qiuying Li,Shiqi Bao,Xuemei Zhang,Jing Chen,Qing Meng,Bolin Chen,Peng Jiang,Liang Wang,Yue Chen
DOI: https://doi.org/10.3390/md18030176
2020-01-01
Marine Drugs
Abstract:Jahanyne, a lipopeptide with a unique terminal alkynyl and OEP (2-(1-oxo-ethyl)-pyrrolidine) moiety, exhibits anticancer activity. We synthesized jahanyne and analogs modified at the OEP moiety, employing an α-fluoromethyl ketone (FMK) strategy. Preliminary bioassays indicated that compound 1b (FMK–jahanyne) exhibited decreased activities to varying degrees against most of the cancer cells tested, whereas the introduction of a fluorine atom to the α-position of a hydroxyl group (2b) enhanced activities against all lung cancer cells. Moreover, jahanyne and 2b could induce G0/G1 cell cycle arrest in a concentration-dependent manner.
What problem does this paper attempt to address?